Published in

Future Medicine, Future Oncology, 10(16), p. 597-612, 2020

DOI: 10.2217/fon-2019-0810

Links

Tools

Export citation

Search in Google Scholar

Global hotspots and future prospects of chimeric antigen receptor T-cell therapy in cancer research: a bibliometric analysis

Journal article published in 2020 by Ming Liu ORCID, Ya Gao ORCID, Yuan Yuan, Shuzhen Shi, Kelu Yang, Jiarui Wu, Junhua Zhang, Jinhui Tian
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Aim: Our study aimed to analyze the characteristics of papers published on CAR T-cell in the field of cancer and explore the existing hot topics and prospects. Materials & methods: We explored the global hotspots and future prospects regarding CAR T-cell therapy in cancer research. Papers of CAR T-cell research were retrieved from the Web of Science database. Analysis was performed using VOSviewer, CiteSpace and Excel software. Results: A total number of 1994 papers related to CAR T-cell research of cancer were included. Molecular Therapy published the most papers (n = 85, 4.26%). A total of 9792 authors participated in the publication of all papers. 62 countries and 2065 institutions have participated in the publication of all papers. Conclusion: Research trends are to improve the immunosuppressive microenvironment of cancer, optimize the structure of CAR T-cells and develop ‘super CAR T-cell’ by using gene-editing technology.